2025-04-11 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Report

**0. Key Figures Overview:**

* **Cumulative Return (ISRG):** 111.98%
* **Cumulative Return (VOO):** 65.78%
* **Return Difference:** 46.2%
* **Relative Return Difference:** 41.3% (This means ISRG's outperformance relative to VOO is in the 41.3th percentile of historical return differences, based on the provided min and max values.)
* **Current Price:** $489.52
* **5-Day Moving Average:** $477.06
* **20-Day Moving Average:** $492.47
* **60-Day Moving Average:** $546.01
* **RSI:** 49.39
* **PPO:** 0.44
* **Market Risk Indicator (MRI):** 0.43 (Medium Risk)
* **Expected Long-Term Return (vs. S&P 500):** 53.4%


**1. Company Overview and Performance Comparison:**

Intuitive Surgical Inc. is a leading developer and provider of robotic-assisted minimally invasive surgery systems.  ISRG significantly outperformed the S&P 500 (VOO) over the analyzed period, showing a cumulative return of 111.98% compared to VOO's 65.78%. The 46.2% difference is substantial and places ISRG's performance in the upper quartile of its historical performance relative to the S&P 500.  Alpha values in the provided table indicate consistent outperformance relative to the market (positive alpha). Beta values reveal a high sensitivity to market movements, particularly in recent years (2021-2025).

**Alpha and Beta Analysis:**  The table shows varying CAGR (Compound Annual Growth Rate) and MDD (Maximum Drawdown) values over different time periods. While high CAGRs are observed, the recent periods show lower growth and even negative returns, highlighting the volatility of the stock.  The increasing beta reflects heightened market sensitivity in recent years.


**2. Recent Price Movement:**

The stock price of ISRG ($489.52) is below its 20-day and 60-day moving averages, suggesting a potential short-term bearish trend. The recent price drop (-$6.39) from the previous close highlights a significant downward movement.


**3. Technical Indicators and Market Sentiment:**

The RSI of 49.39 is near the neutral level (50), indicating neither overbought nor oversold conditions.  A PPO value of 0.44 suggests positive momentum. The recent relative divergence (-14.5%) points to a short-term downtrend. The MRI of 0.43 classifies the current market risk as medium. The significant negative change in price ('Last-market') supports the bearish short-term outlook.


**4. Recent Earnings Analysis:**

| Date       | EPS  | Revenue      |
|------------|------|--------------|
| 2024-10-18 | 1.59 | $2.04B       |
| 2024-07-19 | 1.48 | $2.01B       |
| 2024-04-19 | 1.54 | $1.89B       |
| 2023-10-20 | 1.18 | $1.74B       |
| 2023-10-18 | 1.18 | $1.74B       |

Earnings show relatively consistent revenue figures, with some fluctuation in EPS.  Further analysis is needed to determine the trend.  Note the duplicated data point for October 18, 2024 which needs clarification.

**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $2.41B | 68.04%       |
| 2024-09-30 | $2.04B | 67.41%       |
| 2024-06-30 | $2.01B | 68.30%       |
| 2024-03-31 | $1.89B | 65.87%       |
| 2023-12-31 | $1.93B | 66.24%       |

Revenue is increasing, and profit margins are consistently high and stable, indicating strong financial health.

**Capital and Profitability:**

| Quarter | Equity  | ROE   |
|---------|---------|-------|
| 2024-12-31 | $16.43B | 4.17% |
| 2024-09-30 | $15.58B | 3.63% |
| 2024-06-30 | $14.71B | 3.58% |
| 2024-03-31 | $13.96B | 3.90% |
| 2023-12-31 | $13.31B | 4.56% |

Equity is increasing steadily, but ROE shows some fluctuation, warranting further investigation.

**6. Overall Conclusion:**

ISRG has historically outperformed the S&P 500 significantly. However, recent price action indicates a short-term bearish trend. While the financial statements suggest strong profitability and growth,  the recent price decline and medium market risk level require caution. The high beta suggests sensitivity to market fluctuations.  Further investigation is needed to fully understand the recent dip, including examination of potential news or market factors that have influenced the stock price.  A long-term investment approach, as indicated by the high expected long-term return, could be considered, but careful monitoring of the market and the company's performance is crucial.  The duplicated data point in the earnings report needs to be corrected for accurate analysis.
